At Exscalate we harness the capabilities of supercomputing and cutting-edge technology to deliver a truly transformational drug discovery platform. These capabilities are unlocking value for our partners.
New cures, faster
Our Success Stories
Read how we have already partnered with innovative biotech start-ups - such as Aramis Bioscience (a Harvard University spin-off) and Engitix (a University College London spin-off) - to accelerate their drug discovery journey with some very promising results.